Abstract: Semiconductor quantum dots (QDs) are a new class of fl uorescent labels with broad applications in biomedical imaging, disease diagnostics, and molecular and cell biology. In comparison with organic dyes and fl uorescent proteins, quantum dots have unique optical and electronic properties such as size-tunable light emission, improved signal brightness, resistance against photobleaching, and simultaneous excitation of multiple fl uorescence colors. Recent advances have led to multifunctional nanoparticle probes that are highly bright and stable under complex in vitro and in vivo conditions. New designs involve encapsulating luminescent QDs with amphiphilic block copolymers, and linking the polymer coating to tumor-targeting ligands and drug-delivery functionalities. These improved QDs have opened new possibilities for real-time imaging and tracking of molecular targets in living cells, for multiplexed analysis of biomolecular markers in clinical tissue specimens, and for ultrasensitive imaging of malignant tumors in living animal models. In this article, we briefl y discuss recent developments in bioaffi nity QD probes and their applications in molecular profi ling of individual cancer cells and clinical tissue specimens.
Introduction
The ability to study molecular and cellular events by using fl uorescent probes has broadly impacted many areas in biomedical research including cell biology, molecular biology, drug screening, and molecular diagnostics. However, traditional fl uorophores such as organic dyes and fl uorescent proteins suffer from several intrinsic problems including rapid photobleaching, spectral cross talking, narrow excitation profi les, and limited brightness/signal intensity. In contrast, semiconductor quantum dots (QDs) are fl uorescent nanoparticles based on entirely different principles, and exhibit novel optical and electronic properties that are not available from organic dyes and fl uorescent proteins. These properties include size-and composition-tunable emission from visible to infrared wavelengths, large absorption coeffi cients across a wide spectral range, and improved signal brightness and photostability . Due to their broad excitation profi les and narrow/symmetric emission spectra, high-quality QDs are also well suited for multiplexed tagging or encoding, in which multiple colors and intensities are combined to encode thousands of genes, proteins, or small-molecule compounds (Han et al 2001) .
These properties have raised new opportunities for analyzing a panel of genes and proteins in cancer cells and clinical tissue specimens. Previous work in cancer molecular profi ling has revealed a strong correlation between biomolecular signatures (or biomarkers) and cancer behavior (Liotta and Petricoin 2000) . However, clinical tumor specimens (especially human breast and prostate tumors) are highly heterogeneous, containing a mixture of benign, cancerous, and stromal cells. Current technologies for molecular profi ling include RT-PCR, gene chips, protein chips, two-dimensional gel electrophoresis, biomolecular mass spectrometry (eg, MALDI-MS, ES-MS, and SELDI-MS), but these technologies are not designed to handle this type of cellular heterogeneities (Liotta and Petricoin 2000) . Also, these techniques are "destructive" because they require cells and tissue specimens to be processed into a homogeneous solution, leading to a loss of valuable 3-D cellular and tissue morphological information associated with the original tumor.
The development of nanotechnology, especially bioconjugated nanoparticles, could provide an essential link by which biomarkers are functionally correlated with disease behavior (Ferrari 2005) . In particular, QD probes can be used to quantify a panel of biomarkers on intact cancer cells and tissue specimens, allowing a correlation of traditional histopathology and molecular signatures for the same materials (Gao et al 2003) . This integration may be achieved with a spectral imaging microscope that is designed to operate both in the morphological staining mode and the molecular profi ling mode. In the following, we discuss the novel optical properties of QDs, recent advances in probe development, and their applications in molecular analysis of intact cancer cells and tissue specimens.
Quantum dots
For use in biology and medicine, QD probes most frequently take the form shown in Figure 1 , with an inorganic semiconductor core surrounded by a monolayer of ligands and an amphiphilic polymer coat that is linked to biomolecules. QD cores are most commonly prepared from cadmium selenide (CdSe), a binary semiconductor with size-dependent bandgap energy that can be tuned to emit light of any color throughout the visible spectrum. CdSe QDs have been thoroughly studied and can be produced in large quantities with fl uorescence emission effi ciencies as high as 90% at room temperature (Qu and Peng 2002; Pan et al 2005; Yin and Alivisatos 2005) . These crystalline CdSe cores are synthesized and capped with a protective zinc sulfi de (ZnS) shell in a high temperature organic solvent ( Murray et al 1993; Hines and Guyot-Sionnest 1996; Dabbousi et al 1997) , and are coated with a monolayer of nonpolar coordinating ligands such as trioctylphosphine oxide (TOPO).
After synthesis, the nonpolar, hydrophobic QDs are transferred to an aqueous phase, a nontrivial process that is crucial to the generation of high-quality QDs. Amphiphilic polymers, such as polyethylene glycol (PEG)-modifi ed lipids and octylamine-modifi ed polyacrylic acid (Dubertret et al 2002; Wu et al 2003) , have been used to produce water-soluble QDs that maintain the optical properties and colloidal stability of the original nanoparticles. Previous phase transfer methods involved an exchange of the TOPO ligands for hydrophilic ligands, resulting in QDs with reduced quantum yields and a tendency to aggregate. After transfer to water, QDs may be cross-linked to a variety of biologically active molecules such as antibodies, enzymes, nucleic acids, small molecule inhibitors, or biologically inert PEG. Many coupling schemes have been used to generate cross-links, such as electrostatic adsorption (Mattoussi et al 2000) , covalent bond formation (Chan and Nie 1998; Wu et al 2003) , and biomolecular bridging via streptavidin-biotin binding (Goldman et al 2002; Wu et al 2003) . These methods give rise to QD probes that are highly stable and have excellent affi nity toward their targets, although it is diffi cult to control the number and orientation of biomolecules attached to a single QD.
In comparison with organic dyes and fl uorescent protein, QDs have several advantages and unique applications. ) of organic dyes. Thus, QDs are 10-50 times more effi cient in adsorbing photons than organic dyes at the same excitation photon fl ux, leading a signifi cant improvement in probe brightness. Second, QDs are several thousand times more stable against photobleaching than dye molecules, allowing extended imaging and quantitative biomarker studies of cells and tissue specimens. Third, QDs have size-and composition-tunable fl uorescence emission from visible to infrared wavelengths, and one light source can be used to excite multiple colors of fl uorescence emission. This leads to very large Stokes spectral shifts (measured by the distance between the excitation and emission peaks) that can be used to further improve detection sensitivity. This factor becomes especially important for clinical tissue studies and in-vivo animal imaging due to the high autofl uorescence background often seen in complex biomedical specimens. Indeed, the Stokes shifts of semiconductor QDs can be hundreds of nanometers, depending on the wavelength of the excitation light. Organic dye signals are often buried by strong tissue autofl uorescence, whereas QD signals can be readily separated from the background by wavelength-resolved or spectral imaging (Gao et al 2004) .
Imaging and tracking of cellular events
Live cell imaging often involves transgenic expression of fl uorescently tagged proteins (Miyawaki et al 2003) , but this technique is labor-intensive and the resulting fl uorescent proteins are not suffi ciently bright or stable for singlemolecule imaging and tracking. To address this problem, recent work has shown that QDs microinjected into the cytoplasm of a single cell of a frog embryo could maintain stable and bright fl uorescence over long periods of excitation and observation, allowing real time imaging of embryonic development and cellular tracking (Dubertret et al 2002) . Importantly, injection of a large number of QD particles into an individual cell did not appear to negatively impact embryonic development or cause toxicity. In 2004, Derfus et al (2004) demonstrated that QDs conjugated to organelletargeted peptides could translocate to either nuclei or mitochondria following microinjection into the cytoplasm. Microinjection is, however, a labor-intensive technique and requires delicate manipulation of one cell at a time. Other techniques for QD delivery across cellular membranes include chemical-mediated transfection (cationic peptides, cationic lipids, transferrin proteins) and electroporation (Chen and Gerion 2004; Derfus et al 2004; Jaiswal et al 2004) . Many types of cells are also able to engulf or take up QDs spontaneously via endocytosis, which has led to a QD-based cellular motility assay (Pellegrino et al 2003; Voura et al 2004) as well as imaging of cancer cell extravasation in living animals (Voura et al 2004) . However, these delivery methods are all hampered by aggregation of QDs in the cytoplasm or trapping of the QD probes in endosomes, vesicles, and other intracellular organelles. Working with largely aggregated QDs, Nan et al (2005) measured the motions of multi-protein molecular machines such as kinesin and dynein. By tracking the paths of cationic peptide-conjugated QDs inside cells, their data showed directional, nonBrownian motion that was consistent with the involvement of molecular motors. Recent work in our own lab has shown that cellular membrane pores formed by bacterial toxins like streptolysin O (SLO) are large enough to allow the diffusion of single QDs into the cellular cytoplasm, while maintaining cellular viability. A major fi nding is that the SLO-delivered QD probes are primarily single dots and they maintain their fl uorescence and blinking characteristics. Figure 2 shows confocal fl uorescence images of single dots and aggregates in the cytoplasm of live fi broblast cells.
It is also signifi cant that QD probes have been used to image and track cell surface proteins with considerable success. In particular, Lidke et al (2004) conjugated epidermal growth factor (EGF) to QDs in order to fl uorescently image the binding of EGF to erbB/HER receptors on the membranes of cells. The authors were able to observe individual blinking QDs on the cell surface (corresponding to single receptor molecules), and record the endocytosis and endosomal traffi cking of the receptors in real time. The high photostability and brightness of these probes made possible the observation of a previously unreported transport mechanism from cellular fi lopodia to the cell body (Lidke et al 2005) . Similarly, Dahan et al (2003) reported that QDs conjugated to antibody fragments against the GlyR receptor could be used to observe single receptors on the membranes of neurons. The use of QD probes has allowed real-time imaging and tracking of single receptor molecules over an extended period of time.
Moleculr profi ling of individual cancer cells
Several groups have used multicolor QD probes for molecular profi ling of fi xed cancer cells. Wu et al reported the potential of QDs in 2001 with a variety of multicolor labeling experiments on fi xed cells, demonstrating signifi cant sensitivity and photostability of QD probes compared to the best available organic dyes (Wu et al 2003) . Now that these probes are commercially available, their superiority to conventional dyes has been well established in many fi xed cell labeling experiments. With their narrow emission bandwidths, QDs have also been used to simultaneously label up to 5 biomarkers on the same fi xed cells, a task that is nearly impossible with conventional dyes due to fl uorophore crosstalk and the need for multiple excitation sources. In another development, QDs have been used to simultaneously label fi xed cells for mRNA and protein, combining immunocytochemistry and fl uorescence in situ hybridization (Matsuno et al 2005) . Furthermore, QDs have been used as dual-modality imaging probes, showing bright contrast in fl uorescent micrographs of cells and tissues, and their corresponding electron micrographs (Nisman et al 2004; Giepmans et al 2005) . It is clear that QD probes have opened new possibilities in multiplexed analysis of cellular biomarkers or antigens. As an example, Figure 3 shows color fl uorescence images of human prostate cancer cells that were stained with up to fi ve QD colors, allowing multiplexed analysis of up to fi ve tumor antigens on single intact cancer cells.
It is also important to note that the use of multiplexed QD probes further allows spatial mapping of tumor antigens on single cells. For example, Figure 4 shows fl uorescence images of single breast cancer cells labeled with a cocktail of antibody-QD probes, together with control PBMC cells that do not express the tumor antigens. Remarkably, Cancer molecular profi ling with quantum dots all three colors were observed from breast tumor cells (a and b), while no QD binding was detected with either the control QDs (c) or the control PBMC cells (d). Due to antigen clustering and colocalization, fl uorescence imaging showed overlapping Her-2 and epithelial specifi c antigen (ESA or EpCam) signals on the surface of BT-474 cells (a). The BT-20 cells were found to have a ring of expressed ESA on the cellular peripherals and a much lower level of Her-2. In contrast to stable QD signals, fl uorescence from dye-labeled cells was photobleached in less than 20 seconds (e and f), preventing quantitative imaging or spectroscopic studies at the single-cell level. QDs are considerably brighter and more photostable than organic fl uorophores, which should allow sensitive detection of low-abundance cellular targets through signal averaging and background subtraction. For statistical studies of heterogeneous cell populations, we measured more than 100 cancer cells with a fl uorescence microscope and a spectrometer. The results reveal that the BT-474 cells are clustered in a "high Her-2" area, and that BT-20 cells are clustered in a "low Her-2" area. In clinical samples, a panel of selected markers could be analyzed to provide information on disease staging and treatment options.
Clinical tissue specimens and correlation with tumor behavior
A major application of quantum dots will be in multiplexed labeling and molecular analysis of pathological tissue specimens. In comparison with single cells, clinical tissue specimens are often highly heterogeneous (containing different cell populations in various microenvironments) and are much more diffi cult to analyze. Taking advantage of the high photostability of QDs, Tokumasu and Dvorak (2003) were able to collect 40 consecutive optical sections using confocal microscopy and generated a 3-D reconstructed, high-resolution image of the membrane domain band 3 in erythrocytes. Ness et al (2003) developed an immunohistochemical protocol that combines conventional enzymatic signal amplifi cation and QD labeling to detect intracellular antigens in rat and mouse brain tissue sections. Their study showed that QD immunofl uorescence labeling had greater sensitivity than similar IHC approaches using conventional dyes (Ness et al 2003) . Wu et al (2003) developed reliable and specifi c QD probes to localize the breast cancer cell surface marker Her2, cytoskeleton fi bers, and nuclear antigens in fi xed cells, live cells, and tissue sections, with a substantial increase in brightness and photostability as compared to organic dyes. Taking advantage of the superior photostability of QDs, Ferrara et al (2006) were able to obtain a 3D visualization of the vascular endothelium from an en face preparation of human coronary artery by taking large z-stacks series. All these studies demonstrate that QDs are excellent probes with improved signal-to-noise ratios, and are well suited for studying complex biological problems .
Most studies on QD fl uorescent labeling have been carried out with cells (both live and fi xed) (Tokumasu and Dvorak 2003; Wu et al 2003; Lidke et al 2004) or freshly harvested tissues (Ness et al 2003; Ferrara et al 2006) . However, most available clinical specimens are archived, formalin fi xed, paraffi n-embedded (FFPE) tissues that might be several decades old. Since the clinical outcomes of these tissues are already known, it will be great value to use these specimens for examining the relationship between molecular profi le and clinical outcome. Compared with cells or animal tissues, archived clinical specimens need special treatment such as antigen retrieval, and their background autofl uorescence is generally much stronger than that observed in cells. Our group has developed highly successful procedures for QD staining of archival FFPE tissue specimens. One example is to study the epithelial-mesenchymal transition (EMT) process in the progression of prostate cancer to the bone. EMT is a normal biological mechanism fi rst reported in embryonic development and later found to be involved in cancer metastasis (Huber et al 2005) . During EMT, cancer cells undergo phenotypical changes and become more invasive, characterized by changes in the profi le change of cellular adhesion molecules, particularly, an increase of N-cadherin and a loss of E-cadherin. Other important markers include the cytoskeleton proteins vimentin, cytokeratin 18 and RANKL. In one example, we have used QD-conjugated secondary antibodies (Qdots Corporation, now Invitrogen) for molecular profiling of two FFPE androgen-repressed prostate cancer (ARCaP) cells lines. These two cell lines were selected because they represent two phenotypes at the two ends of the EMT process during prostate cancer progression. The ARCaP E is more epithelial-like and less invasive, while the ARCaP M has more mesenchymal characteristics and more invasive (Zhau et al 1996) . Our QD staining studies have achieved simultaneous staining of 4 different biomarkers with expression profi les consistent with western blot data ( Figure 5 ). Moreover, QD staining also provides spatial localization information (both inter-and intracellular) which is not possible with western blot or any molecular biology techniques. We have also found that staining of FFPE cells requires longer incubation time (overnight at 4 o C vs 1 hour at room temperature) and Xing et al a higher QD-secondary antibody concentration than that required for freshly fi xed cells. For molecular profiling of clinical FFPE prostate specimens, we also selected four tumor antigens (mdm-2, p53, EGR-1 and p21) as a model system for technology development. These markers are known to be important in prostate cancer diagnosis and are correlated with tumor behavior (Hernandez et al 2003; Mora et al 2005) . As shown in Figure 6 , we were able to detect all 4-markers in the tissue specimens, but the autofl uorescence was higher than that observed in FFPE cells. Compared with FFPE cells, clinical tissue specimens may require harsher antigen retrieval conditions (EDTA buffer vs citrate buffer) and generally have stronger autofl uorescence. On the other hand, autofl uorescence can be desirable by serving as counterstaining of tissue morphology. Autofl uorescence can be separated from the QD signal by intentionally illuminating the sample to bleach it out while leaving the QDs bright enough for imaging and spectral analysis. Of course, spectral unmixing algorithms can be developed or obtained commercially (Mansfi eld et al 2005) to separate the background fl uorescence from the real QD signals. In summary, these results demonstrate the feasibility of using QDs as fl uorescent labels for molecular profi ling of FFPE clinical specimens. With continuous efforts in optimizing the experimental conditions, we believe that QD probes hold great promise in multiplexed molecular profi ling of clinical tissue specimens and correlation of biomarkers with disease behavior.
In conclusion, semiconductor quantum dots have emerged as a new class of fl uorescent tags for molecular profi ling of single cancer cells and clinical tissue specimens. With only a single light source, multicolor fl uorescence imaging allows rapid screening and selection of cancer cells, and wavelength-resolved spectroscopy provides quantitative data on the expression levels of multiple biomarkers. It should be possible to simultaneously determine the expression levels of 8-10 genes or proteins in single cells. With spectroscopic multiplexing, it might even be possible to analyze 50-100 of genes and proteins on morphologically intact cells or tissue specimens. In addition to molecular pathology and in-vitro diagnostics, QD probes have shown promise as contrast agents for in vivo tumor imaging in living animals (Gao and Nie 2004; Voura et al 2004; Stroh et al 2005) . Thus, we expect QD-based imaging and diagnostic technologies to have broad applications in linking biomolecular signatures with disease behavior, and will play a signifi cant role in personalized and predictive medicine.
